PressPort logo
https://www.pressport.com/us/news/pressreleases/biosimilars-market-to-see-27-58-cagr-globally-by-2018-says-a-research-report-available-at-reports-and-intelligence-19777

Biosimilars Market to see 27.58% CAGR Globally by 2018, says a Research Report available at Reports and Intelligence

Press release February 6, 2015

The report covers Americas, EMEA and APAC regions; it also covers the Global Biosimilars market landscape and its growth prospects in the coming years.

Reports and Intelligence adds a report titled “Global Biosimilars Market 2014-2018.” As per the report, the global biosimilars market is expected to register a CAGR of 27.58% during the forecast period i.e. 2013-2018.

The market is driven by the growing number of patent expirations in the field of biosimilars. However, drug failure risks continue to hinder the growth of the global biosimilars market. Furthermore, the market is expected to witness a high rate of outsourcing the manufacturing of biosimilar drugs, which would help to further propel the growth of the global market.

The report on the global biosimilar market is a comprehensive study of the global market and provides insightful information on the market dynamics and various factors influencing the growth of the market. The report provides a detailed analysis of the latest market trends, drivers & restraints, technologies, research and development activities, geographical regions and leading companies in the field of biosimilars.

Browse detailed report at:  http://www.reportsandintelligence.com/global-biosimilars-2014-2018-market

The geographical regions covered in the report are EMEA, APAC and America. The study would help to evaluate the market size of the biosimilars market across the aforementioned geographical regions and unveil the potential opportunities across the global market.

The report also profiles the leading companies in the global biosimilar market. The study helps the readers to understand the strategies adopted by the various companies in order to gain competitive advantage in the global market.

Companies profiled in the report are Hospira Inc., Biocon Ltd., Mylan Inc., 3SBio Inc., Celltrion Inc., Novartis AG, Intas Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Amgen Inc., Actavis plc,  AstraZeneca plc, Biogen Idec Inc., Baxter International Inc., Bioton S.A., Cipla Ltd., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim GmbH, Coherus Biosciences Inc., GE Healthcare Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline plc, GeneScience Pharmaceuticals Co. Ltd., iBio Inc., Pfizer Inc., LG Life Sciences Co. Ltd., JCR Pharmaceuticals Co. Ltd., Merck & Co. Inc., Samsung Biologics Co. Ltd., Ranbaxy Laboratories Ltd., Wockhardt Ltd. and Sanofi S.A.

Contact Us:

Deep Joshi

5933 NE Win Sivers Drive,
#205, Portland, OR 97220 
United States

Direct: +1 (617) 674-4143

Toll Free: +1 (855) 711-1555

Fax: +1 (855) 550-5975

Email us: help@reportsandintelligence.com

Web:http://www.reportsandintelligence.com

LinkedIn: https://www.linkedin.com/company/reports-and-intelligence

Subjects


Biosimilars Market 2014-2018 Biosimilars Market Growth Global Biosimilars Market Biosimilars Market Trends Biosimilars Market